$IBM

IBM Gets Closer to Fault-Tolerant Quantum Computing with New Cryogenic System - TipRanks.com

IBM announced a milestone in quantum computing, connecting and cooling two cryogenic modules to scale quantum computers. The company aims for a 1,000-qubit system by 2027 and a fault-tolerant quantum computer by 2029. IBM shares are slightly down in pre-market trading after a 1.67% gain on Tuesday, closing at $232.67. Analysts give IBM a Moderate Buy consensus with an average price target of $255.78, suggesting 10% upside.

Original reporting
Published Aug 30, 2026, 1:13 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 30, 2026, 1:48 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefTechnology
Primary signal
$IBM
Neutral
medium confidence
Mentioned
$IBM
Relevance
7/10
AlphAI data visualization · based on tipranks.com
Decision brief

The 30-second read

$IBMNeutralLow
01

Why it matters

The announcement underscores IBM's progress toward a fault‑tolerant quantum computer, supporting its long‑term strategic positioning but offering limited immediate price catalyst.

02

Market read

While the milestone is positive for IBM's quantum ambitions, the near‑term market impact appears muted; investors may adjust long‑term exposure to quantum tech.

03

What to watch

Potential cost overruns and timeline delays could outweigh technical gains.

Relevance 7/10Novelty 7/10Timing: pre‑market today

Background

IBM reported a new engineering milestone in its quantum computing program, linking two cryogenic modules and targeting 1,000 qubits by 2027, with shares slightly down pre‑market.

Company-level read

Ticker impact

$IBMNeutralMedium confidence
Context

IBM announced successful connection and cooling of two cryogenic quantum modules, a step toward its 1,000‑qubit fault‑tolerant target.

Expected impact

Short‑term modest dip or flat; medium‑term upside if progress continues.

Evidence & confidence

Technical progress is positive but does not immediately change revenue outlook; market reaction modest.

Market effects

Advances may pressure competing quantum players (Google, Microsoft) and boost sector interest.

U.S. tech sector could see slight positive sentiment toward IBM; limited broader impact.

Highlights ongoing global race for fault‑tolerant quantum computers.

Counterpoint

Investors may view the modest pre‑market dip as a sign of over‑hyped expectations and short the stock.

Key entities

  • IBM

    U.S. technology firm developing quantum computers.

  • Nighthawk processor

    Processor to be installed in the new cryogenic modules for testing.

Related articles

$IBMMed

IBM Stock Decline and Future Outlook

IBM's stock has fallen 22% year-to-date, trading near $230. The company lowered its 2026 revenue outlook to 4%-5% due to slowing software revenue growth. Despite this, IBM expects free cash flow to grow by $1 billion, supporting dividends. Analysts forecast a potential stock price of $310 in five years if growth continues. IBM also invested $1 billion in Anderon LLC's quantum technology initiative, backed by a $1 billion U.S. government grant.

$IBMMedAI 8/10

IBM To Build First U.S. Quantum Microchip Foundry

IBM (IBM) received a $1 billion U.S. grant from the U.S. Commerce Department to build the first U.S. quantum microchip foundry. IBM will invest $1 billion U.S. in its subsidiary Anderon, which will operate the foundry. The project is part of a U.S. government initiative to advance quantum computing and AI. The foundry will be located in New York and serve multiple companies. IBM's stock has fallen 4% over the past year to $248.37 U.S. per share.

$NOKMed

In AI Infrastructure Race, Nokia’s Optical Bet Outpaces IBM’s Software Pivot

Nokia (NOK) rose 63% year-to-date, driven by AI and cloud revenue doubling, while IBM (IBM) fell 20% due to a 42% drop in mainframe revenue. Nokia expects 18-20% growth in IP and Optical segments, supported by a new U.S. chip fab. IBM cut its full-year guidance to 4-5%, citing deferred deals. Both companies have similar five-year returns, but their year-to-date performance diverged sharply.

$IBMHighAI 9/10

A $1 Billion Reason Why IBM Stock Is Up Today

IBM received a $1 billion federal award to boost quantum wafer manufacturing at its subsidiary, Anderon. The company matched this with $1 billion in internal funding. IBM shares are down 17% year-to-date but offer a 2.82% dividend yield. Analysts see a 45% upside potential, with a consensus 'Moderate Buy' rating and a $365 price target.

$IBMMed

Trump Provides Fresh Boost To Quantum Computing Space, Signs Two Orders - IBM, INFQ, QBTS, RGTI, QUBT Stocks In Focus

President Trump signed two orders to accelerate U.S. quantum tech development and enhance cybersecurity. The first aims for a functional quantum computer by 2028, while the second mandates quantum-resistant encryption by 2031. IBM, IONQ, and QUBT stocks rose 4-6% after-hours. The Department of Commerce also allocated $2 billion for commercial quantum development.